Researchers have introduced AceFF, a new machine learning interatomic potential (MLIP) designed for small molecule drug discovery. This model refines the TensorNet2 architecture and is trained on a large dataset of drug-like compounds to balance speed with accuracy. Two versions, AceFF-2 and AceFF-2-OMOL, are available, supporting various chemical elements and charged states, and have demonstrated state-of-the-art performance on benchmarks relevant to drug discovery. AI
IMPACT This new ML potential could accelerate drug discovery by providing faster and more accurate simulations for small molecules.
RANK_REASON The cluster describes a new machine learning model released as an arXiv preprint, detailing its architecture and performance on scientific benchmarks. [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →